These specimens, along with associated de-identified patient data, has allowed Quadrant Life Sciences to materially expand its research and development pipeline to include ADHD, Depression and Diabetes, among other medical conditions.
Our database will continue to grow as we’ve partnered with a pediatric practice currently covering 49 states with access to over 90% of the US childhood population. This demographic encompasses a well-covered Medicaid population, which is crucial for meeting diversity and inclusion criteria.
We have the data, processes, procedures, and resources you need to develop and run your successful clinical trial. Accessing our biobank data can supplement prospective collections and reduce timelines. These specimens are perfect for DNA and RNA sequencing.
Quadrant offers an experienced team with a broad range of development resources including:
- IRB and regulatory management
- Site support and project management
- Data management and analysis
- Machine learning and AI development
Biobanking by the numbers:
- 163k+ unique patients
- 617k+ total specimens
Interested in Prospective Collections?
Quadrant has deep experience running nationwide clinical research studies. These can be paired with our biobank’s inventory, or conducted independently.
Contact us for more details